Cargando…
FOXO3a-ROS pathway is involved in androgen-induced proliferation of prostate cancer cell
BACKGROUND: Although FOXO3a can inhibit the cell proliferation of prostate cancer, its relationship with reactive oxygen species (ROS) in prostate cancer (PCa) has not been reported. METHODS: We analyzed the correlation between the expression of FOXO3a and the antioxidant enzyme catalase in prostate...
Autores principales: | Tao, Yan, Liu, Shanhui, Lu, Jianzhong, Fu, Shengjun, Li, Lanlan, Zhang, Jing, Wang, Zhiping, Hong, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052560/ https://www.ncbi.nlm.nih.gov/pubmed/35488328 http://dx.doi.org/10.1186/s12894-022-01020-9 |
Ejemplares similares
-
Rapamycin inhibits AR signaling pathway in prostate cancer by interacting with the FK1 domain of FKBP51
por: Zhang, Jing, et al.
Publicado: (2020) -
Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
por: Zhao, Yu, et al.
Publicado: (2014) -
Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways
por: Qian, Kaiyu, et al.
Publicado: (2016) -
Androgen receptor reverts dexamethasone-induced inhibition of prostate cancer cell proliferation and migration
por: Guo, Ju, et al.
Publicado: (2018) -
Juglanthraquinone C Induces Intracellular ROS Increase and Apoptosis by Activating the Akt/Foxo Signal Pathway in HCC Cells
por: Hou, Ya-Qin, et al.
Publicado: (2016)